Combined effects of interferon-alpha and acyclovir on herpes simplex virus type 1 DNA polymerase and alkaline DNase (Q45754237)

15 December 2017

title

Combined effects of interferon-alpha and acyclovir on herpes simplex virus type 1 DNA polymerase and alkaline DNase (English)

1 reference

15 December 2017

Herpes simplex virus type 1

main subject

1 reference

1 reference

J L Taylor

1

1 reference

15 December 2017

P Tom

series ordinal

2

1 reference

15 December 2017

W J O'Brien

series ordinal

3

1 reference

15 December 2017

publication date

1 May 1998

1 reference

15 December 2017

published in

Antiviral Research

1 reference

15 December 2017

volume

38

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

95-106

1 reference

15 December 2017

Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of her

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Combination Therapy for Dendritic Keratitis with Human Leukocyte Interferon and Acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Synergistic activity of combinations of recombinant human alpha interferon and acyclovir, administered concomitantly and in sequence, against a lethal herpes simplex virus type 1 infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

A Phase I/II Trial of Zidovudine, Interferon- , and Granulocyte-Macrophage Colony-Stimulating Factor in the Treatment of Human Immunodeficiency Virus Type 1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Combination Therapy for Dendritic Keratitis With Acyclovir and -Interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

A DNA binding protein specific for an origin of replication of herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Potent synergistic inhibition of herpes simplex virus-2 by 9-[(1, 3-dihydroxy-2-propoxy) methyl]guanine in combination with recombinant interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with alpha-interferon against herpes simplex virus type 2 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Synthesis of Herpes Simplex Virus Proteins in Interferon-treated Human Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Cloning of herpes simplex virus type 1 sequences representing the whole genome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Alpha interferon and acyclovir treatment of herpes simplex virus in lymphoid cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Combined effects of acyclovir and human interferon-alpha on herpes simplex virus replication in cultured neural cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Combined interaction of antiherpes substances and interferon ? on the multiplication of herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Synergistic inhibitory effect of acyclovir and human native beta-interferon on the growth of herpes simplex virus type 2 in human embryo fibroblast cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Different effects of IFN gamma and IFN alpha/beta on "immediate early" gene expression of HSV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Comparison of exonucleolytic activities of herpes simplex virus type-1 DNA polymerase and DNase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Herpes simplex virus type 1 alkaline nuclease is required for efficient processing of viral DNA replication intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

The product of a 1.9-kb mRNA which overlaps the HSV-1 alkaline nuclease gene (UL12) cannot relieve the growth defects of a null mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Synergism between recombinant human interferon and nucleoside antiviral agents against herpes simplex virus: examination with an automated microtiter plate assay

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Nucleoside metabolism in herpes simplex virus-infected cells following treatment with interferon and acyclovir, a possible mechanism of synergistic antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

The effects of interferon-alpha and acyclovir on herpes simplex virus type-1 ribonucleotide reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Synergistic antiviral activity of acyclovir and interferon on human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Combination therapy for dendritic keratitis. High-titer alpha-interferon and trifluridine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Combined anti-herpes virus activity of nucleoside analogs and interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Regulation of herpes simplex virus thymidine kinase in cells treated with a synergistic antiviral combination of alpha interferon and acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

The comparative anti-herpes simplex virus effects of human interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Bromovinyldeoxyuridine and interferon treatment in ulcerative herpetic keratitis: a double masked study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Treatment of Cytomegaloviral Pneumonia with High-Dose Acyclovir and Human Leukocyte Interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Demonstration of the human herpesvirus 6-induced DNA polymerase and DNase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900008-4

7 January 2021

10.1016/S0166-3542(98)00008-4

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

9707372

1 reference

15 December 2017